International audienceTwo isolates of enterohemorrhagic Escherichia coli (EHEC) O104:H4 were isolated in France in 2004 and 2009. Both were characterized and compared to the strain which caused the German outbreak in 2011 and to other O104:H4 strains. This suggests that different O104:H4 EHEC strains were present several years prior to the 2011 outbreak. From May to July 2011, a large-scale outbreak of enterohe-morrhagic Escherichia coli (EHEC) was observed in several European countries, mainly affecting northern Germany. Altogether , about 4,000 cases of EHEC infections and nearly 50 fatalities were reported (8). This outbreak also led to massive economic losses for farmers and to widespread public concern, after various vegetables and sprouts as well as a possible bio-terrorist attack were publicly discussed as possible sources of the infection. Recent epidemiological studies singled out imported fenugreek seeds, although this has not yet been substantiated by laboratory evidence (6). In order to understand the evolution and possibly the origin of the recent outbreak strain, it is of great interest to identify related or ancestral isolates. Only a few cases of infections caused by E. coli O104:H4 were described earlier than 2011. One was a case of hemolytic-uremic syndrome (HUS) from South Korea (1), but the causative strain appeared not to be closely related to the current European outbreak strain, differing in toxin carriage, resistance properties, and pulsed-field gel electrophoresis profiles (10). Another one originated from Italy in 2009 (18). A recently described and fully sequenced strain, HUSEC 41 isolate 01-0991, originated from a HUS case in Germany in 2001 (4, 11). Prior to the 2011 outbreak, E. coli O104:H4 was also detected in two isolated clinical cases in France. One patient was a 6-year-old male child from the Lyon area treated for HUS in 2009. He was hospitalized, treated with azithromycin, and cured. The other one was an adult male patient with hemor-rhagic colitis from the town of Lille, in northern France, in 2004. The clinical course and outcome are not known. Both isolates were characterized by microarray analysis using a previously described system (9), and they yielded identical hybri